Membranous glomerulonephritis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
*The treatment of hepatitis c can prevent the can lower the risk for membranous glomerulonephritis. | *The treatment of hepatitis c can prevent the can lower the risk for membranous glomerulonephritis{{cite journal |vauthors=Gyapay G, Jeney A, Lapis K |title=Drug action and chromatin structure. I. Adriamycin binding to core particle of nucleosomes and subsequent enhanced DNA fragmentation induced by micrococcal nuclease |journal=Neoplasma |volume=32 |issue=5 |pages=521–8 |date=1985 |pmid=4069286 |doi= |url=}} | ||
==References== | ==References== | ||
Revision as of 20:45, 18 July 2018
|
Membranous glomerulonephritis Microchapters |
|
Differentiating Membranous glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranous glomerulonephritis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Membranous glomerulonephritis secondary prevention |
|
Membranous glomerulonephritis secondary prevention in the news |
|
Directions to Hospitals Treating Membranous glomerulonephritis |
|
Risk calculators and risk factors for Membranous glomerulonephritis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]
Overview
- Early detection and treatment of hepatitis C can be preventive for developing membranous glomerulopathy
Secondary Prevention
- The treatment of hepatitis c can prevent the can lower the risk for membranous glomerulonephritisGyapay G, Jeney A, Lapis K (1985). "Drug action and chromatin structure. I. Adriamycin binding to core particle of nucleosomes and subsequent enhanced DNA fragmentation induced by micrococcal nuclease". Neoplasma. 32 (5): 521–8. PMID 4069286.